Biofrontera Balance Sheet Health
Financial Health criteria checks 4/6
Biofrontera has a total shareholder equity of $4.8M and total debt of $3.9M, which brings its debt-to-equity ratio to 81.5%. Its total assets and total liabilities are $27.9M and $23.1M respectively.
Key information
81.5%
Debt to equity ratio
US$3.90m
Debt
| Interest coverage ratio | n/a |
| Cash | US$1.42m |
| Equity | US$4.79m |
| Total liabilities | US$23.14m |
| Total assets | US$27.93m |
Recent financial health updates
Recent updates
Biofrontera Inc. (NASDAQ:BFRI) Not Doing Enough For Some Investors As Its Shares Slump 28%
Dec 30
The Market Doesn't Like What It Sees From Biofrontera Inc.'s (NASDAQ:BFRI) Revenues Yet As Shares Tumble 43%
Nov 13Can Biofrontera (NASDAQ:BFRI) Afford To Invest In Growth?
Oct 18Biofrontera announces preliminary Q3 product revenue, stock falls ~7% after hours
Oct 05Biofrontera gets notice of allowance for U.S. patent covering a nanoemulsion formulation
Sep 06Biofrontera GAAP EPS of -$0.05, revenue of $4.5M; reaffirms FY22 guidance
Aug 12Biofrontera announces 2Q prelim product revenues
Jul 12Financial Position Analysis
Short Term Liabilities: BFRI's short term assets ($23.1M) exceed its short term liabilities ($18.1M).
Long Term Liabilities: BFRI's short term assets ($23.1M) exceed its long term liabilities ($5.1M).
Debt to Equity History and Analysis
Debt Level: BFRI's net debt to equity ratio (51.8%) is considered high.
Reducing Debt: Insufficient data to determine if BFRI's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BFRI has sufficient cash runway for 1 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: BFRI is forecast to have sufficient cash runway for 1 months based on free cash flow estimates, but has since raised additional capital.